South Korean researchers at KAIST unveiled an AI system intended to detect early signs of cerebrovascular disease at home by monitoring subtle behavioral changes in older adults. The platform, developed through collaboration led by KAIST, uses contactless sensors to analyze daily activity patterns, sleep quality, circadian rhythms, and indoor environmental factors. This approach targets a practical bottleneck in cerebrovascular risk management: frequent, low-friction screening outside clinical settings. If validated, home monitoring could help identify early risk signals and route individuals to confirmatory testing. For biotech and digital health investors, the value proposition is likely in scalability—contactless sensor-based inference can reach populations that are difficult to bring into specialty clinics on a regular basis. The extract does not specify clinical performance metrics or regulatory pathway, but the described system design suggests an emphasis on longitudinal behavioral signals rather than single time-point biomarker testing.